FCMR and neoplasm: On the other hand, IgM may promote tumor progression by driving EMT, expanding immunosuppressive populations such as MDSCs, impairing antigen presentation through FcμR signaling, and fostering immune evasion via persistent IgM expression and inhibited class-switch recombination.